Tag Archives: Could

Novartis’ new cell therapy facility could ease manufacturing squeeze for CAR-T med Kymriah

Novartis’ big push into cell and gene therapy hasn’t been the smoothest of rides, with a data manipulation scandal hamstringing Zolgensma and manufacturing concerns hurting CAR-T cancer therapy Kymriah. Could a new European facility help turn around the latter’s production bottleneck?  Novartis last week opened its newest cell and gene therapy facility in Stein, Switzerland,… Read More »

Cancer symptoms: Can you hear this noise? You could be at risk of this type of cancer

Cancer is the uncontrolled growth of abnormal cells in the body which develop when the body’s normal control mechanism stops working. Cancer survival outcomes greatly depend on the type and stage of the cancer so recognising the warning signs is key to improving outcomes. A symptom associated with a rare type of cancer relates to… Read More »

Why the medicine you take could actually be bad for your health – New Scientist

Rushing medicines to market is supposed to help people in need. But relying on lower standards of evidence may ultimately cause more harm than good. Health 27 November 2019 By Jessica Hamzelou Tassii/Getty Images WEEKS before their due date, some women find themselves stunned, peering through glass at their baby, a tiny body covered in… Read More »